Similar Articles

Use of Clozapine in the Treatment-Resistant Schizoprenia

Oğuzhan Kütük

DOI: 10.5606/jebms.2020.75609

Issue: 2020, Volume 1 - Issue 1
885 815

Glucagon-Like Peptide-1 and Psychiatric Disorder

Ayşe Şiva Acar, Oytun Erbaş

DOI: 10.5606/jebms.2021.75645

Issue: 2021, Volume 2 - Issue 2
1590 1186

Brain-Derived Neurotrophic Factor (BDNF) Polymorphism and Depression-Suicide

İlayda Üzümcü, Oytun Erbaş

DOI: 10.5606/jebms.2021.75654

Issue: 2021, Volume 2 - Issue 2
530 505

Synaptic Vesicle Protein 2A: Basic Facts and Roles in Schizophrenia

Aylin Kayaaltı, Berzah Güneş, Oytun Erbaş

DOI: 10.5606/jebms.2021.75677

Issue: 2021, Volume 2 - Issue 3
1093 354

Neuregulin 1 and Its Roles in Schizophrenia: A Systematic Review

Dildar Savcı, Sultan Karadeniz, Oytun Erbaş

DOI: 10.5606/jebms.2021.75683

Issue: 2021, Volume 2 - Issue 3
523 461

Gluten and Casein: Their Roles in Psychiatric Disorders

Ayşegül Şimal Ulaş, Arzu Çakır, , Oytun Erbaş

DOI: 10.5606/jebms.2022.1003

Issue: 2022, Volume 3 - Issue 1
2655 841

Understanding the Role of DISC1 in Psychiatric Disorders

Şeyda Yazıcı, Hadi Sasani, Oytun Erbaş

DOI: 10.5606/jebms.2022.1011

Issue: 2022, Volume 3 - Issue 1
601 314

Schizophrenia Susceptibility Genes

Beyza Nur Akı, Oytun Erbaş

DOI: 10.5606/jebms.2022.1027

Issue: 2022, Volume 3 - Issue
318 329

An Overview of Antipsychotics: Mechanisms of Action

Öznur Demirci, İrem Adar, Oytun Erbaş

DOI: 10.5606/jebms.2023.1047

Issue: 2023, Volume 4 - Issue 1
940 439